Table 2.
Unadjusted linear regression models for cm outcomes by probiotic use (Yes).
| Outcome | Estimate | 95% CI | p-value |
|---|---|---|---|
| A1c (%) | −0.18 | (−0.27, −0.08) | < 0.001 |
| HDL-C (mg/dL) | 3.16 | (1.98, 4.34) | < 0.001 |
| LDL-C (mg/dL) | −3.39 | (−8.10, 1.32) | 0.16 |
| Total Cholesterol (mg/dL) | −1.98 | (−6.07, 2.11) | 0.34 |
| Triglyceride Level (mg/dL) | −20.40 | (−31.35, −9.45) | <0.001 |
| ASCVD Risk Score (%) | −0.02 | (−0.04, −0.01) | 0.01 |
| Blood Pressure (systolic) (mmHg) | −1.41 | (−2.84, 0.03) | 0.06 |
| Blood Pressure (diastolic) (mmHg) | −1.50 | (−2.73, −0.28) | 0.02 |
| BMI (kg/m2) | −0.32 | (−0.88, 0.24) | 0.26 |
HDL-C, High-density lipoprotein cholesterol; LDL-C, Low-density lipoprotein cholesterol; ASCVD, Atherosclerotic cardiovascular disease; BMI, Body mass index. Bold formatting indicates p-values of statistical significance.